• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Blood eosinophils do not predict inhaled budesonide response in bronchiectasis.

作者信息

Aliberti Stefano, Sotgiu Giovanni, Martinez Garcia Miguel-Angel

机构信息

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy

Università degli Studi di Milano, Dept of Pathophysiology and Transplantation, Milan, Italy.

出版信息

Eur Respir J. 2020 Sep 3;56(3). doi: 10.1183/13993003.02210-2020. Print 2020 Sep.

DOI:10.1183/13993003.02210-2020
PMID:32883760
Abstract
摘要

相似文献

1
Blood eosinophils do not predict inhaled budesonide response in bronchiectasis.血液嗜酸性粒细胞不能预测支气管扩张症患者吸入布地奈德的反应。
Eur Respir J. 2020 Sep 3;56(3). doi: 10.1183/13993003.02210-2020. Print 2020 Sep.
2
Blood eosinophils predict inhaled fluticasone response in bronchiectasis.血液嗜酸性粒细胞可预测支气管扩张症患者对吸入氟替卡松的反应。
Eur Respir J. 2020 Aug 20;56(2). doi: 10.1183/13993003.00453-2020. Print 2020 Aug.
3
Bronchiectasis: defining specific treatment needs.支气管扩张症：明确特定治疗需求。
Chest. 2012 Mar;141(3):825. doi: 10.1378/chest.11-2079.
4
Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis.布地奈德福莫特罗在非囊性纤维化支气管扩张症中的临床疗效和安全性。
Chest. 2012 Feb;141(2):461-468. doi: 10.1378/chest.11-0180. Epub 2011 Jul 21.
5
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.吸入用环索奈德与吸入用布地奈德、吸入用倍氯米松或吸入用氟替卡松治疗成人慢性哮喘的系统评价
BMC Fam Pract. 2006 Jun 5;7:34. doi: 10.1186/1471-2296-7-34.
6
Systemic effects of fluticasone on blood eosinophils in bronchiectasis.氟替卡松对支气管扩张症患者血液嗜酸性粒细胞的全身影响。
Eur Respir J. 2020 Sep 3;56(3). doi: 10.1183/13993003.02005-2020. Print 2020 Sep.
7
Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma.吸入性氟替卡松与吸入性倍氯米松或吸入性布地奈德治疗慢性哮喘的比较
Cochrane Database Syst Rev. 2004(2):CD002310. doi: 10.1002/14651858.CD002310.pub2.
8
Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD.沙美特罗+氟替卡松与福莫特罗+布地奈德吸入联合疗法对慢性阻塞性肺疾病患者的支气管扩张作用。
Respir Med. 2003 May;97(5):453-7. doi: 10.1053/rmed.2002.1455.
9
Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma.吸入用沙美特罗/丙酸氟替卡松联合制剂与布地奈德对哮喘患者健康相关生活质量的影响。
Am J Respir Med. 2002;1(6):435-40. doi: 10.1007/BF03257170.
10
Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review.比较布地奈德/福莫特罗固定剂量复方制剂与其他吸入性皮质类固醇/长效β2 受体激动剂复方制剂治疗慢性阻塞性肺疾病患者的疗效：一项综述。
Expert Rev Respir Med. 2019 Nov;13(11):1087-1094. doi: 10.1080/17476348.2019.1665514. Epub 2019 Sep 13.

引用本文的文献

1
Gallbladder and biliary pathology: lessons learned from multidisciplinary conference.胆囊与胆道病理学：多学科会议的经验教训
Abdom Radiol (NY). 2025 Feb;50(2):916-935. doi: 10.1007/s00261-024-04533-z. Epub 2024 Sep 11.
2
HACOR score to predict NIV failure in patients with COVID-related hypoxemic respiratory failure managed in the ordinary ward and in the critical care setting.HACOR 评分预测在普通病房和重症监护病房管理的 COVID 相关低氧性呼吸衰竭患者中接受有创机械通气的失败风险。
Intern Emerg Med. 2024 Nov;19(8):2319-2329. doi: 10.1007/s11739-024-03628-1. Epub 2024 May 13.
3
Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis.
血嗜酸性粒细胞百分比可预测支气管扩张症患者对吸入性皮质类固醇的反应。
Clin Respir J. 2023 Jun;17(6):548-555. doi: 10.1111/crj.13624. Epub 2023 Apr 26.
4
Research advances and clinical management of bronchiectasis: Chinese perspective.支气管扩张症的研究进展与临床管理：中国视角
ERJ Open Res. 2022 Apr 11;8(2). doi: 10.1183/23120541.00017-2022. eCollection 2022 Apr.
5
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity.非囊性纤维化支气管扩张症患者的表型聚类：嗜酸性粒细胞在疾病严重程度中的作用。
Int J Environ Res Public Health. 2021 Aug 10;18(16):8431. doi: 10.3390/ijerph18168431.
6
T2-High Endotype and Response to Biological Treatments in Patients with .T2高内型与……患者对生物治疗的反应
Biomedicines. 2021 Jul 2;9(7):772. doi: 10.3390/biomedicines9070772.
7
Protease-Antiprotease Imbalance in Bronchiectasis.支气管扩张症中的蛋白酶-抗蛋白酶失衡。
Int J Mol Sci. 2021 Jun 1;22(11):5996. doi: 10.3390/ijms22115996.